Related Experiment Video
Updated: Jul 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
[Caffeine and birth weight--randomised double blind trial]
Bodil Hammer Bech1, Carsten Obel, Tine Brink Henriksen
1Aarhus Universitet, Institut for Folkesundhed, Afdeling for Epidemiologi, Arhus C. bhb@soci.au.dk
Caffeine intake in pregnancy has been linked to adverse outcome, but evidence from non-experimental studies on impaired fetal growth remains equivocal. We carried out a randomised double blind trial to estimate the effect of reducing caffeine intake on birth weight and the length of gestation. We found no differences in mean birth weight or mean length of gestation between women randomised to caffeinated coffee and women randomised to decaffeinated coffee. A moderate reduction in caffeine intake in the second half of pregnancy has no effect on birth weight or the length of gestation.
Caffeine intake in pregnancy has been linked to adverse outcome, but evidence from non-experimental studies on impaired fetal growth remains equivocal. We carried out a randomised double blind trial to estimate the effect of reducing caffeine intake on birth weight and the length of gestation. We found no differences in mean birth weight or mean length of gestation between women randomised to caffeinated coffee and women randomised to decaffeinated coffee. A moderate reduction in caffeine intake in the second half of pregnancy has no effect on birth weight or the length of gestation.
More Related Videos
08:33Experimental Protocol for Examining Behavioral Response Profiles in Larval Fish: Application to the Neuro-stimulant Caffeine
Published on: July 24, 2018
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Experimental Designs
Blind Procedures
Regression Toward the Mean
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.